Fundz

Fundz Deep Dive

Everything you need to win Nate Fernhoff — in one platform.

Who to reach, what to say, and why now on Nate Fernhoff — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Nate Fernhoff — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Orca Bio Appoints Nate Fernhoff As Chief Executive Officer

PRIVATEMay 13, 2025about 1 year ago

Position

Chief Executive Officer

Company

Orca Bio

Nate Fernhoff
Menlo ParkBiotechnologyHealth CareTherapeutics

Description

Orca Bio has announced the appointment of Nate Fernhoff, Ph.D., as Chief Executive Officer, succeeding Ivan Dimov, Ph.D. Jeroen Bekaert, Ph.D., has been appointed as President, further strengthening the company's leadership team.

Company Information

Company

Orca Bio

Location

Menlo Park, California, United States

About

Orca Bio is a late-stage biotechnology company dedicated to transforming the lives of patients through high-precision cell therapy. The company is focused on developing innovative T-cell immunotherapies for the treatment of blood cancers. Their lead investigational products, Orca-T and Orca-Q, are currently being evaluated in pivotal clinical trials. Orca Bio aims to deliver high-precision therapies to patients who could greatly benefit from improved treatment options.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Orca Bio's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.